Immunic News - IMUX

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Immunic Inc IMUX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.11 1.24% 8.95 8.80 9.10 8.98 8.84 16:30:00
more quote information »

Recent News

Date Time Source Heading
2/11/202006:30PRNUSImmunic, Inc. to Participate in Scientific and Investor..
1/10/202016:07EDGARStatement of Changes in Beneficial Ownership (4)
1/10/202016:06EDGARInitial Statement of Beneficial Ownership (3)
1/08/202007:20EDGARCurrent Report Filing (8-k)
1/08/202006:30PRNUSImmunic Exercises its Option for the Exclusive Worldwide..
12/20/201916:59EDGARStatement of Ownership (sc 13g)
12/06/201916:41EDGARCurrent Report Filing (8-k)
12/04/201907:01EDGARCurrent Report Filing (8-k)
12/04/201906:30PRNUSImmunic, Inc. to Present Data on IMU-856, for the First..
11/25/201906:30PRNUSImmunic, Inc. to Participate in Investor and Scientific..
11/19/201917:53EDGARStatement of Changes in Beneficial Ownership (4)
11/19/201917:51EDGARInitial Statement of Beneficial Ownership (3)
11/19/201907:00EDGARCurrent Report Filing (8-k)
11/19/201906:30PRNUSImmunic, Inc. Expands Board of Directors with Appointment of..
11/07/201916:16EDGARCurrent Report Filing (8-k)
11/07/201916:15EDGARQuarterly Report (10-q)
11/07/201916:01PRNUSImmunic, Inc. Reports Third Quarter 2019 Financial Results..
11/05/201906:30PRNUSImmunic, Inc. to Participate in Industry and Investor..
10/15/201917:03EDGARStatement of Changes in Beneficial Ownership (4)
10/15/201917:01EDGARInitial Statement of Beneficial Ownership (3)
10/15/201907:02EDGARCurrent Report Filing (8-k)
10/15/201906:30PRNUSImmunic, Inc. Expands Board of Directors with Appointment of..
10/10/201916:01PRNUSImmunic, Inc. Announces Completion of Enrollment for its..
10/04/201908:01EDGARCurrent Report Filing (8-k)
9/30/201906:30PRNUSImmunic, Inc. to Participate in Investor and Scientific..
9/20/201916:07EDGARSecurities Registration: Employee Benefit Plan (s-8)
9/18/201906:30PRNUSImmunic, Inc. Doses First Healthy Volunteer in its Phase 1..
9/11/201906:30PRNUSImmunic, Inc. to Present Selected Available and Previously..
9/05/201916:08EDGARCurrent Report Filing (8-k)
9/05/201916:00PRNUSImmunic, Inc.'s Interim Dosing Analysis of IMU-838 as Part..
9/03/201906:30PRNUSImmunic, Inc. to Participate in Scientific and Investor..
8/12/201906:30PRNUSImmunic, Inc. Announces First Patient Enrolled in..
8/08/201908:17EDGARCurrent Report Filing (8-k)
8/08/201908:12EDGARQuarterly Report (10-q)
8/08/201906:30PRNUSImmunic, Inc. Reports Second Quarter 2019 Financial Results..
8/05/201908:46EDGARStatement of Changes in Beneficial Ownership (4)
8/02/201917:01EDGARStatement of Changes in Beneficial Ownership (4)
8/01/201906:30PRNUSImmunic AG Awarded Research Grant by German Federal Ministry..
7/30/201906:30PRNUSImmunic, Inc. to Present at the Canaccord Genuity 39th..
7/24/201917:49EDGARStatement of Changes in Beneficial Ownership (4)
7/24/201917:48EDGARStatement of Changes in Beneficial Ownership (4)
7/24/201917:47EDGARStatement of Changes in Beneficial Ownership (4)
7/24/201912:03EDGARInitial Statement of Beneficial Ownership (3)
7/17/201917:21EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
7/17/201917:16EDGARCurrent Report Filing (8-k)
7/17/201907:32EDGARCurrent Report Filing (8-k)
7/16/201906:30PRNUSImmunic, Inc. Appoints Sanjay S. Patel, CFA, as Chief..
6/24/201906:30PRNUSImmunic, Inc. to Present Previously Unpublished Data..
6/21/201908:30PRNUSImmunic, Inc. Files Financial Statements and Pro Forma..
6/21/201908:24EDGARCurrent Report Filing (8-k)
See more news about this stock »

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.